HON. RON PAUL OF TEXAS
BEFORE THE US HOUSE OF REPRESENTATIVES
November 10, 2005

Free Speech and Dietary Supplements

Mr. Speaker, I rise to introduce the Health Freedom Protection Act. This bill restores the First Amendment rights of consumers to receive truthful information regarding the benefits of foods and dietary supplements by codifying the First Amendment standards used by federal courts to strike down the Food and Drug Administration (FDA) efforts to censor truthful health claims. The Health Freedom Protection Act also stops the Federal Trade Commissions (FTC) from censoring truthful health care claims.

The American people have made it clear they do not want the federal government to interfere with their access to dietary supplements, yet the FDA and the FTC continue to engage in heavy-handed attempts to restrict such access. The FDA continues to frustrate consumers efforts to learn how they can improve their health even after Congress, responding to a record number of constituents comments, passed the Dietary Supplement and Health and Education Act of 1994 (DSHEA). FDA bureaucrats are so determined to frustrate consumer access to truthful information that they are even evading their duty to comply with four federal court decisions vindicating consumers First Amendment rights to discover the health benefits of foods and dietary supplements.

FDA bureaucrats have even refused to abide by the DSHEA section allowing the public to have access to scientific articles and publications regarding the role of nutrients in protecting against diseases by claiming that every article concerning this topic is evidence of intent to sell a drug.

Because of the FDAs censorship of truthful health claims, millions of Americans may suffer with diseases and other health care problems they may have avoided by using dietary supplements. For example, the FDA prohibited consumers from learning how folic acid reduces the risk of neural tube defects for four years after the Centers for Disease Control and Prevention recommended every woman of childbearing age take folic acid supplements to reduce neural tube defects. This FDA action contributed to an estimated 10,000 cases of preventable neutral tube defects!

The FDA also continues to prohibit consumers from learning about the scientific evidence that glucosamine and chondroitin sulfate are effective in the treatment of osteoarthritis; that omega-3 fatty acids may reduce the risk of sudden death heart attack; and that calcium may reduce the risk of bone fractures.

The Health Freedom Protection Act will force the FDA to at last comply with the commands of Congress, the First Amendment, and the American people by codifying the First Amendment standards adopted by the federal courts. Specifically, the Health Freedom Protection Act stops the FDA from censoring truthful claims about the curative, mitigative, or preventative effects of dietary supplements, and adopts the federal courts suggested use of disclaimers as an alternative to censorship. The Health Freedom Protection Act also stops the FDA from prohibiting the distribution of scientific articles and publications regarding the role of nutrients in protecting against disease.

This legislation also addresses the FTCs violations of the First Amendment. Under traditional First Amendment jurisprudence, the federal government bears the burden of proving an advertising statement false before censoring that statement. However, the FTC has reversed the standard in the case of dietary supplements by requiring supplement manufactures to satisfy an unobtainable standard of proof that their statement is true. The FTCs standards are blocking innovation in the marketplace.

The Health Freedom Protection Act requires the government bear the burden of proving that speech could be censored. This is how it should be in a free, dynamic society. The bill also requires that the FTC warn parties that their advertising is false and give them a chance to correct their mistakes.

Mr. Speaker, if we are serious about putting people in charge of their health care, then shouldn’t we stop federal bureaucrats from preventing Americans from learning about simple ways to improve their health. I therefore call on my colleagues to stand up for good health care and the First Amendment by cosponsoring the Health Freedom Protection Act.

LifeWave patches work with the electromagnetic energy field of the body to induce desired affects. Nothing enters the body through the skin.

I regularly use the RestQuiet patches to sleep like a log. One patch on the right temple, or on an accupressure point just under the right collarbone works great. A single patch works for a minimum of two nights.

You can order a test kit for $14.95. If they work for you like they work for me you won’t go anywhere without them. Order LifeWave patches by calling (866) 420-6288 and giving them my distributor number 603396 or by clicking on:
http://www.lifewave.com/603396

While most people have had a cardiogram, few know that Einthoven won a Nobel prize in 1924 for discovering how to record the electromagnetic field of the heart. Even fewer know that this field is now detectable from 15 feet away from your body and that every cell has an electromagnetic field that can alter its behavior when manipulated. Thus the basic work has already been done to chart the direction for building a StarTrek Tricorder which can detect a diseased energy pattern and manipulate it towards health. Somes devices are already on the market that, while primitive compared to a Tricorder, do the job remarkably well.

Many people attribute energy medicine effects to the placebo effect. The placebo effect is always there in any clinical encounter or clinical study. It is an important and real effect with the body often generating real chemical compounds as strong as the most powerful drug.

Most scientists don’t know that every patient at the Stanford Medical Center when I was there studying biostatistics was in a clinical trial in order to take advantage of the placebo effect on all patients, not just the ones getting a new treatment. The National Institute of Medicine, notes in a recent publication, that the brain changes induced by opiates are the same as that induced by a placebo effect. It is far safer and often more affective to induce a placebo effect, than to give a drug with negative side effects, particularly when the response is the same or better.

Frequency medicine works on dogs and cats as well as on humans and there is little chance of a psychological induced placebo effect there, particularly when treatment is remote and they are not aware anything is being done. And there is a huge amount of scientific data on real electromagnetic effects in carefully controlled human studies enumerated by Oschman. To bad most physicians never read these papers.

Enough said. These comments suggest that ignorance of the scientific literature in this field is widespread, even among leading scientists, and the first prescription for the brain disfunction resulting from this lack of knowledge is Oschman’s book. I recommend it to all my colleagues.

It has been puzzling to me that every cancer patient I test for a Lyme infection turns out positive. My ongoing research on Lyme has focused in recent weeks on a mycoplasma that lies at the root of the disease. It appears to be the fundamental factor that severely depresses the immune system allowing the entire complex of pathogenic bacteria, fungi, parasites, and viruses to proliferate. A recent study shows that “chronic infection or colonization by mycoplasma(s) could gradually and significantly alter many biologic properties of mammalian host cells in culture, including induction of malignant transformation.”

Therefore, in those individuals with cancer, it is important to eliminate the Rife BX/BY “virus”, the Gregory “cancer virus”, the SV40 virus, and Lyme disease. Failing to do this sets the individual up for progression and/or recurrence of malignancy.

Mycoplasma fermentans infection promotes immortalization of human peripheral blood mononuclear cells in culture.

Zhang S, Tsai S, Wu TT, Li B, Shih JW, Lo SC
Department of Infectious and Parasitic Diseases Pathology, American Registry of Pathology, Washington DC, USA.

Blood. 2004 Dec 15;104(13):4252-9. Epub 2004 Aug 26

Chronic infection or colonization by mycoplasma(s) could gradually and significantly alter many biologic properties of mammalian host cells in culture, including induction of malignant transformation. We examined effects of Mycoplasma fermentans infection on the continuing survival and immortality of human peripheral blood mononuclear cells (PBMCs) from healthy blood donors. Without specific supplemental growth factors, human PBMCs normally die rapidly, with few cells other than macrophages/monocytes surviving after 2 weeks in cultures. Only occasional Epstein-Barr virus (EBV)-positive B lymphocytes would continue to proliferate and undergo spontaneous immortalization. Our present study revealed that infection of human PBMCs in culture with the incognitus and PG18 strains of M fermentans, but surprisingly not with some other strains tested in parallel, markedly enhanced the rate of EBV-positive B lymphocytes to undergo immortalization (74% vs 17%). Compared with spontaneously immortalized PBMCs, the PBMCs immortalized in cultures infected with the mycoplasmas often had prominent karyotype changes with chromosomal loss, gain, or translocations. Furthermore, many of these immortalized B lymphocytes were found to be monoclonal in nature. The in vitro findings would be of relevance to lymphoproliferative disorders that occurred in patients with immune suppression. The mycoplasma-mediated promotional effect in cell immortalization and its potential clinical implications warrant further study.

The Nanobacteria Link
to Heart Disease and Cancer

Nanoparticles are implicated in the harmful calcification that’s common to many illnesses. A simple treatment is now reversing the symptoms, especially in heart disease, so why aren’t the health authorities telling patients and doctors about it?

Millions of seriously ill patients are unaware that heart disease is being measurably reversed with an approach pioneered by researchers at the National Aeronautics and Space Administration (NASA) and in Finland, aided by Mayo Clinic and Washington Hospital Center findings. This approach is now prescribed by hundreds of doctors for thousands of patients. A similar approach has been developed with prostate disease at the renowned Cleveland Clinic in Florida. According to doctors, both approaches are practical options for those whose other medicines and surgery have failed. So why aren’t other desperately ill patients whose treatments don’t work being told about it?

In July 2004, the medical journal Pathophysiology published a peer-reviewed research paper with the innocuous title “Calcification in coronary artery disease can be reversed by EDTA–tetracycline long-term chemotherapy”.1 In plain terms, it meant that hardening of the arteries was being reversed. Not only were rock-hard calcium deposits being reduced, but chest pains were being resolved in most patients and bad cholesterol levels were being cut beyond what other medicines had achieved. The findings were important for patients whose other drugs and surgery weren’t working, i.e., the “cardiac cripples”, whose numbers are in the millions and whose doctors have told them there is nothing more to be done. They were the ones who responded most favourably to the new approach.

Then, in February 2005, a paper published in the prestigious Journal of Urology by researchers from the Cleveland Clinic, one of the leading urology hospitals in America, reported “significant improvement” in chronic prostatitis—a growing problem for millions of men—again, where other approaches had failed.

The studies, although otherwise separate, had a compelling link. They used a cocktail of well-known, inexpensive medicines that have been around for half a century but were never before used in this combination. Both reports urged more studies to confirm their conclusions, and emphasised that not every patient experienced a reversal; only a majority did. Nonetheless, the results were encouraging. Chronic diseases that had befuddled modern medicine were being reversed.

To put a human face on this, take the case reported by Dr Manjit Bajwa of McLean, Virginia, who did not participate in the clinical studies but whose experience with one patient paralleled study results. Dr Bajwa reported in a testimonial of 5 May 2005:

“Two years ago I had a patient with severe coronary artery disease with a 75–85% blockage in left coronary and two other arteries. Open heart surgery was recommended as stents could not be put in. The patient was told he would probably die within two weeks if surgery was not performed.

“He declined surgery and instead chose chelation. [Author’s note: chelation in this case is an intravenous form of heavy metal removal.] After twenty-five treatments of chelation, his angina worsened [author’s emphasis]. With [his] heart calcium score of 2600, I started the nanobacteria protocol. Within two to three weeks his angina abated. He was able to return to all his normal activities and exercises in two months.

“Nanobacteria protocol helped this patient measurably, when other treatments had failed. I am quite impressed with his results. With heart calcium scores of 750 or more, nothing else seems to work.”

I’ve reported on nanobacteria previously. Frequency sets should always be used in combination with oral or IV chelation therapy. In addition, nanobacteria reinfection is common so periodic elimination is required.

The previous frequency reported had some Lyme frequencies, particularly in the 500-700khz range. This is because over 80% of the people I test have at least a light Lyme infection. As I now have a comprehensive set of six different programs for use in eliminating Lyme organisms, I have removed Lyme frequencies from the nanobacteria set. It should be noted that many humans or animals with a heavy nanobacteria infection will have a concurrent Lyme infection that needs to be addressed.

Nanobacteria frequencies are regularly updated and now available to Frequency Foundation subscribers. See link on side of page to sign up.

I’ve reported before on evolutionary biology and how important and rare it is to inject this thinking into medicine and public health. Frequency research can be used to target specific bacteria for elimination mimicking the strategies now being used in antibiotic research.

Battling Evolution to Fight Antibiotic Resistance

For any new antibiotic, resistant bacteria typically show up in four years, or less. Penicillin resistance was reported clinically even before large-scale use of the antibiotic began in 1942. The battle against antibiotic-resistant bacteria demands new drugs and smarter, more responsible ways to use existing ones. Some researchers, however, are pursuing another type of weapon: drugs that sidestep natural selection. Less virulent bacteria would decrease the need for antibiotics, some reason, and drugs that drastically slow mutation rates might cut off evolution’s power source.

Evaluating nonkilling approaches in the lab and clinic is tricky, and outfoxing evolution in the real world could prove even more difficult. Bacteria have evolved their way past ostensibly impenetrable barriers a number of times. Still, even if new approaches only hold off the inevitable, they could be a big win. “Half a loaf is better than none,” says Abigail Salyers, professor of microbiology at University of Illinois Urbana-Champaign. Moreover, since microbe defenses develop so quickly, staying ahead of these pathogens requires more than new drugs that kill bacteria in new ways.

Kikuchi’s disease is associated with benign lymphatic tumors which can be mistaken for lymphoma. It has been associated with Parvovirus B19 (see photo from New York State Dept. of Health). It’s frequency is close to that of the Epstein Barr virus so symptoms may be mistaken for mononuclosis.

This is quite a nasty virus and difficult to eliminate. Any virus will alter cells to become factories for producing the virus so targeting malfunctioning cells is important.

Researchers may want to try the following F165 program as it may be useful in eliminating Parvovirus B19. I’m interested in hearing about any success with this frequency program.

repeat 40
dwell 360
program a
vbackfreq b 0.002478752 0 66.6 #scalar octave
converge .016% 1
4444343 #aberrated cells
vbackfreq b 0.049787068 0 66.6 #scalar octave
converge .044% 1
344777 266780 156666 66666 15544 #Parovirus B19
end repeat

The LifeWave patches are put on the meridians of the body and affect the electromagnetic field, increasing energy level and burning fat. The photo below shows a white patch on the left shoulder and a tan patch on the right shoulder. This will increase the energy level of the body by about 300%. This translates into a physical capability. If you can do 8 repetitions of lifting weights then will the patches you should be able to do 12. Increasing the energy level by 300% translates into a 30-50% greater capacity for lifting weights.

It also translates into better endurance for long driving trips or leading day long seminars on your feet. At the end of the trip or end of the day, you feel as energetic as when you started. You also have more energy during the trip or the day.

A Qi Gong master recently published a book on how to ramp the energy level up signficantly higher. If you put a white patch on each shoulder and put a two tan patches on each leg meridian just below the knee slightly to the outside, you will increase your energy level by 1000%. This has to be experienced to be believed. Peter Ragnar’s 8 repetitions went to 20. My energy level leading seminars is so intense, I seem to have more energy at the end of the day than when I started.

You can get some patches at my LifeWave site. Highly recommended.

LifeWave patches passively interact with the electromagnetic field of the body to increase energy production and burn more calories. Nothing enters the body. Sounds too good to be true, yet Olympic coaches and athletes are using these patches to enhance performance. How do they work?

A BRIEF INTRODUCTION TO THE LifeWave™ TECHNOLOGY AND EXPLANATION OF THE PHENOMENA ASSOCIATED WITH ITS USE
By David Schmidt, President, LifeWave™ Products, LLC

OVERVIEW

• LifeWave™ is a new technology that consists of orthomolecularorganic structures that passively interact with the human body for the purpose of inducing electron flow and thermomagnetic frequency modulation.
• The induced electron flow assists in recruiting calcium ions into the muscle fiber during the contraction phase, allowing the user to utilize more muscle fiber during contraction, thereby allowing theLifeWave™ user to lift heavier weights.
• The passive thermomagnetic frequency modulation of the LifeWave™ technology creates a condition in which the transport of long chain fatty acids across the Mitochondrial membrane for subsequent beta-oxidation and energy production is increased, providing theLifeWave™ user with increased energy and stamina.
• In third party tests conducted independently, over 99% ofLifeWave™ users experienced significant improvements in physical strength after a few minutes of using LifeWave™, with typical increases being 10% and higher.
• In third party tests conducted independently, over 99% ofLifeWave™ users experienced significant increases in stamina after a few minutes of using LifeWave™, with typical increases being 25% and higher.
• All materials in LifeWave™ have been clinically tested for safety and efficacy, and are listed under FDA 21 CFR.
• All LifeWave™ devices are manufactured at FDA registered facilities.
• Patent Pending

ADA Gets “Kiss of Death”…
Opinion by Consumer Advocate Tim Bolen
Sunday, September 18th, 2005

It had to happen sooner or later. The ADA (American Dental Association) has had a long run – with the posse chasing them. I’m surprised they’ve lasted this long.

They’ll scream, they’ll holler, they’ll whine, they’ll whimper. They’ll threaten, and they’ll lash out – but in the end it won’t matter – the American Dental Association is finished. Nail their doors shut. Board up their windows. It’s soon to be all over for them.

The ADA, as we know in the Health Freedom Movement, stateside, is an organization designed to protect the status quo in US dentistry. Never mind that the methods they protect are from two centuries ago.

We also know that a significant part of the ADA’s annual income comes from “product endorsement” (about 42%), and I have a strong feeling that to encourage that “endorsement,” the ADA uses its contact with State Dental Boards, to prosecute Dentists that use products NOT endorsed – leaving a distinctive chill on the market.

I can’t help but wonder if this type of operation were being performed, say, in the Bronx against “mom & pop” small businesses, it’d be run, by guys named “Big Louie, Hatchet Face, Stabbin’ Jack, Dirty Guido, Johnny Leg-Breaker, and Don Alfresco,” and the Feds would be wiretapping corner phone booths.

Isn’t this called a “protection racket?”

Keep in mind that some of the things they protect, and get income from, include mercury amalgams, flouride in water, and root canals.

But that little bit, above, is just window dressing for the incredible story I’m about to tell you. Sit up, because if you don’t – in a minute you’re going to spill your health drink all over your freshly washed hemp shirt.

Ready?

There’s six important Court actions ongoing in the United States (US), all involving the US dental establishment, that cumulatively represent the end of the “status quo” in dentistry, and all that it has protected. As we already know, US dentistry lags far behind the rest of the world, with US dentists acting more like automobile body shops than health professionals – focusing on appearance over health.

The first important Court action is in Tennessee. It’s a lawsuit called “Barnes v. Kerr,” and it is an unusual case. In it, Barnes, a dentist, sued Kerr-McGee, a manufacturer of mercury amalgam for, as DAMS leader Leo Cashman says:

Barnes, who used mercury amalgam fillings for the first ten years of his practice, alleged that he had been poisoned by the mercury in the amalgam fillings that he placed and removed on a daily basis. In 1999, Dr Barnes brought a products liability case against Kerr Corporation, the manufacturer of the only amalgam products Barnes ever purchased. Barnes retained Jim Love and Robert Reeves, attorneys most knowledgeable about mercury amalgams, to represent him. Dr. Mark Richardson, PhD, F.L. Lorscheider, Ph.D., Gary Ordog, M.D., Robert Granacher, M.D., George Colpitts, D.D.S., and other expert witnesses testified on Dr. Barnes’s behalf concerning the various scientific, medical, and dental issues that arose in the case. Kerr challenged the admissibility of Dr. Barnes’s scientific and medical testimony on the basis that it was not supported by valid and reliable published science. However, the trial court ruled that the supporting science was valid and reliable and overruled Kerr’s motion.

Kerr filed an ensuing motion for summary judgment claiming that its warnings were adequate as a matter of law. Kerr also argued that the vast majority of Barnes’s exposure was not attributable to Kerr’s products, but to amalgam fillings that Barnes removed. Because the appearance of an amalgam filling will not reveal the filling’s manufacturer, Kerr argued that Barnes could not prove that Kerr’s products actually injured Barnes. The District Court granted Kerr’s motion. The judgment was appealed to the 6th Circuit U.S. Court of Appeals, but on August 11th, 2005, the Court of Appeals upheld the District Court’s ruling.

If the Sixth Circuit Court’s opinion is published, Barnes v. Kerr may profoundly change the legal landscape regarding amalgam. Barnes argued that Kerr’s warnings addressed only mercury—not mixed dental amalgam. Barnes admitted that he was aware of mercury’s toxicity, but testified that in dental school, he was taught that mixed dental amalgam was safe and the mercury rendered inert. However, the Sixth Circuit’s opinion held that the warning sufficiently notified Barnes that mixed dental amalgam was dangerous. The Court noted, “the label on each jar of dental amalgam capsules featured not only a skull and crossbones next to the word “Poison,” but also a list of illnesses, including “bronchiiolitis, pneumonitis, pulmonary edema [and] redness and irritation to [the] eyes and skin.” Likewise, the Court noted, the MSDS (material safety data sheet, provided to all dentist buyers) warned that chronic mercury exposure could lead to “nervous irritability, weakness, tremors, gingivitis, erethism and graying of the lens of the eye.” Further, the Court ruled that the other ingredients mixed in amalgam with the mercury – silver, copper and tin – are not claimed by the manufacturer to “neutralize the danger while the dentist is working with the product…”

What’s important is the following:

1) Under the “learned intermediary” doctrine, dentists are obligated to pass along manufacturer’s warnings to their patients. In light of the ruling in Barnes v. Kerr, dentists will be required to explain to their patients the dangers acknowledged in Kerr’s warnings.

2) Arguably, state dental boards will no longer be able to prohibit dentists from communicating the dangers of mercury amalgam to their patients.

3) In order for a dentist to obtain a patient’s informed consent, the information given to a patient concerning amalgam will change very dramatically.

4) The Court’s opinion will provide a direct challenge to the ADA’s proclamations of amalgam safety.

5) In formulating a successful legal strategy, Kerr may have impaired the market for its dental amalgam product.

The second important case is in Ohio. It’s called “Kerger v. ADA, et al.” In this case, a woman, Jessica Kerger, sued the ADA, The Ohio Dental Association, and two mercury amalgam manufacturers, for, as Leo Cashman says:

A personal injury lawsuit against them by Jessica Kerger, an Ohio woman, and her family is gaining traction in the courtroom. Judge Nancy A. Fuerst has denied a detailed “motion to dismiss” by the defendants, two dental amalgam manufacturers, the American Dental Association (ADA) and the Ohio Dental Association (ODA). In her complaint, Jessica Kerger alleges that she has suffered neurological deficits and hormonal function problems relating to mercury from her dental amalgam fillings. In 2004, Kerger sued amalgam makers and the ADA and ODA for personal injuries resulting in serious disability. Some parts of the Kerger complaint were dismissed by the court, but key claims were not dismissed, including “fraud, misrepresentation and negligent claims to a third party.”

“The stuff that really matters stayed in,” Jessica Kerger said. The ADA has petitioned Judge Fuerst to clarify her ruling and say why she kept the key charges in court.

Normally, in a case like this (Kerger) I’d shrug my shoulders and “wait and see,” for I know that the ADA will trot out all of it’s usual arguments. Like the tobacco industry, the ADA has been defending these things for years – and knows how to proceed. Which brings us to the third case…

The third important Court action is in Illinois – and it is related to the Kerger case. It’s called “Federal Insurance v. ADA,” and it’s “the kiss of death,” no matter how it’s decided, for the ADA. For, Federal Insurance was the ADA’s insurance carrier during the time Jessica Kerger was being injured. They are no longer their insurer.

Federal Insurance, a division of the CHUBB group, is as Leo Cashman says:

Meanwhile another court will have to determine whether the ADA has any insurance coverage in the Kerger case. The ADA’s former insurer, Federal Insurance Company, has sued the ADA charging that any ADA conduct that would have hurt Jessica Kerger (e.g., caused her to mercury poisoned by dental amalgams) was deliberate and intentional and therefore not covered by its insurance policies with Federal (Federal Insurance provided insurance coverage for ADA from 1965 until January 1, 2000)… The ADA has been the industry’s biggest defender of the dental amalgam (mercury) filling, even going so far as to hold that it is “unethical” for a dentist to replace an amalgam filling out of concern for the toxicity of mercury. It has also obtained revenue for giving its Seal of Approval for the amalgam product sold by the various dental material manufacturers. Without Federal Insurance by its side, ADA would have to be on its own for its defense in the Jessica Kerger case and would be on its own to absorb potentially huge liability lawsuit damages in the Kerger case and others like it.

Federal Insurance Company, established in 1901, is a division of the Chubb Group of Insurance Companies, one of the world’s top global insurance companies. Chubb has over 100 offices, in 30 countries. Even by itself, Federal itself has over $23 billion in assets and a net worth close to $8 billion. If it is now taking an adversarial role towards the ADA and its conduct regarding amalgam, it appears to have the lawyers and the deep pockets to press its case.

The fourth important case is in Colorado – and I’ve spoken about it many times. It’s called the “Cavitat v. Aetna” Federal Lawsuit, which, is by the way, proceeding along nicely. Aetna countersued Cavitat a while back, claiming a whole host of strange things. In it they called me a “Paid Troublemaker,” among other things, and for some reason, every time I read their claim (which, I admit, isn’t often), I have to laugh – even Aetna has problem finding good attorneys, I guess, but there’s a Motion for Dismissal in front of the Judge – so we’ll see what happens.

From reading the Court documents available through the Pacer system on the Cavitat case, it looks as though Aetna’s BIG MOVE is to hide the transcript, from the public, of Robert S. Baratz MD, DDS, PhD’s (“Bobbie Bogus”) deposition in this case.. For what-ever reason, Aetna seems to want that information withheld. Knowing Baratz, and the way he testifies when he’s under fire, his testimony was probably so damning, Aetna’s CEO has probably already written Cavitat a check – they just haven’t delivered it yet… For the most part Aetna relied on Baratz’s statements to attack Cavitat – and that’s why Cavitat sued them.

Baratz, you may remember, made history in a Wisconsin hearing room, a few years ago – when he sweat through his suit while being examined in a three day “credibility hearing,” I helped organize. He also, in Florida, before that, came running into a hearing room shrieking like a girl, claiming “My life is in danger. I need police protection, blah-blah-blah, squeak, squeak, squeak…” just because I was in the building. Then there was that hearing in Boston last June where I showed up…

I FULLY understand why Aetna would want to suppress what Baratz says. That is EXACTLY the right thing to do. BUT, Aetna is more than a little late. They should have suppressed what Baratz, and his “quackbuster” cronies, said about Cavitat BEFORE they put all that crap on their website – the stuff they got sued for.

Now It’s time for Aetna to write a check – or face a Colorado jury, bringing shrieking, sweaty, Bobbie in as their witness. (Insert laughter here). They won’t be able to hide this clown from the jury… Baratz is the best witness Cavitat has – and supposedly, he’s Aetna’s witness…

The fifth important case is in Massachusetts – and I’ve spoken about it only once before. It was the June 6th hearing in Boston story and the case surrounding it. This’ll be the very first time that anyone has outright challenged the use of a quackbuster, like little Bobbie Baratz, as the primary, or only, witness, in a dental case. This case challenges the “ultimate” authority of the ADA. Simply put, so far, several State of Massachusetts employees have been sued for using a known crackpot dirtbag like Bobbie Baratz, and who he represents, as a witness against a reputable dentist. I’ll let you know what happens.

But here’s a little tidbit to think about – the State of Massachusetts did little, if any, checking on Bobbie’s veracity, or his so-called expertise. For instance, Bobbie testified for about six and a half hours about how this dentist improperly installed a dental bridge in a patient’s mouth. On cross-examination Baratz was forced to admit that since 1986 (where in another case he claimed he “no longer practiced dentistry”) he had not installed any bridges. In fact, he has NEVER, EVER, installed a bridge. When asked about how he felt he could testify “as an expert” on a subject he knew NOTHING about, he replied “I researched it…”

Personally, I do not understand why Baratz has survived as a so-called “expert witness” this long. Anyone, and everyone, who uses him should be sued for all that they may own.

The sixth important case is in Wisconsin – and I’ve spoken about it many times. It’s the Vander Heyden case. This a case where the dental establishment simply wanted to flex its muscles. They were going to show the upstart “Biological Dentists” just who had the biggest horns in the pasture. So, without the benefit of the law on their side, or expertise, or much of anything, including a prosecutor who clearly didn’t even know how to organize a case, they charged Rick Vander Heyden with “practicing beyond the scope of Dentistry,” because he once used an electronic device, along with regular diagnostic tools, to help him try and figure out just what was causing a patient a particular problem.

Well, the prosecutor didn’t even bring a witness into the Courtroom at all – none – and certainly no expert witnesses. But that didn’t deter the actual Dental Board from taking Rick’s license away from him. They did. Naturally, it went to Court, and a few days ago, as I expected, the Court reversed the Board’s ruling, staying the revocation – and scheduled a hearing. My feeling – the prosecutor didn’t put on a case in front of the Administrative Law Judge because he already had a “Decision” from key Dental Board members in his pocket.. Vander Heyden was targeted. Now, of course, things have changed.